Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical Candidates

Mihirbaran Mandal, Haifeng Tang, Weidong Pan et al.|Journal of Medicinal Chemistry|2022

Cited by 27